 |
Articles: Other Drugs |
Prior Articles
Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation
Current Medical Research and Opinion, 11/13/09
Lactic Acidosis Associated With Metformin in a Patient With Type 2 Diabetes With No Contraindication
The Endocrinologist, 11/13/09 Benefits and risks of raloxifene by vertebral fracture status
Current Medical Research and Opinion, 11/13/09 Oral nitrate therapy does not affect glucose metabolism in healthy men
Clinical and Experimental Pharmacology and Physiology, 11/13/09 Identification of Dynamin-2-mediated Endocytosis as a New Target of Osteoporosis Drugs, Bisphosphonates
Molecular Pharmacology, 11/13/09 Effects of Achieving an LDL-Cholesterol Level of <70 mg/dL Compared With the Goal of <100 mg/dL Using Simvastatin or Atorvastatin on Cognitive Processes in High-Risk Diabetic Patients
The Endocrinologist, 11/13/09 Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes
Diabetes, Obesity and Metabolism, 11/12/09
Revew Article
Six-month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting
Diabetes, Obesity and Metabolism, 11/12/09 Rediscovering bile acid sequestrants
Diabetes, Obesity and Metabolism, 11/12/09
Revew Article
Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia
Diabetes, Obesity and Metabolism, 11/12/09 Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
Diabetes, Obesity and Metabolism, 11/12/09 Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
Diabetes, Obesity and Metabolism, 11/12/09
Exclusive Author Commentary The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics
Diabetes, Obesity and Metabolism, 11/12/09 Effectiveness of high dose sublingual immunotherapy to induce a stepdown of seasonal asthma: a pilot study
Current Medical Research and Opinion, 11/11/09 Successes and challenges of insulin therapy for type 2 diabetes in a managed-care setting
Current Medical Research and Opinion, 11/11/09 A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09
Free full text
Issues in postmenopausal hormone therapy: A 3-part CME newsletter series Counseling patients about bioidentical hormone preparations
Sexuality, Reproduction & Menopause, 11/11/09
Free full text
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
Clinical Interventions in Aging, 11/11/09
Free full text
Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes Mellitus
Journal of Clinical Endocrinology and Metabolism, 11/10/09 Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/10/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
